Rebecca K Hughes, João B Augusto, Kristopher Knott, Rhodri Davies, Hunain Shiwani, Andreas Seraphim, James W Malcolmson, Shafik Khoury, George Joy, Saidi Mohiddin, Luis R Lopes, William J McKenna, Peter Kellman, Hui Xue, Maite Tome, Sanjay Sharma, Gabriella Captur, James C Moon
BACKGROUND: Apical hypertrophic cardiomyopathy (ApHCM) accounts for ≈10% of hypertrophic cardiomyopathy cases and is characterized by apical hypertrophy, apical cavity obliteration, and tall ECG R waves with ischemic-looking deep T-wave inversion. These may be present even with <15 mm apical hypertrophy (relative ApHCM). Microvascular dysfunction is well described in hypertrophic cardiomyopathy. We hypothesized that apical perfusion defects would be common in ApHCM. METHODS: A 2-center study using cardiovascular magnetic resonance short- and long-axis quantitative adenosine vasodilator stress perfusion mapping...
March 2023: Circulation. Cardiovascular Imaging